Merck & Co (MRK) Stock Insights

MRK$133.72+0.91 +0.69%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$329.65BEnterprise value$373.88BRevenue (TTM)$67.3BMarket positionTop 5%

Score

43
Bearish
Value
38
Quality
61
Growth
30

Insights

  • Revenue by product
  • Revenue by region
Revenue by product
PeriodValue
FY2011Other Segments: 53943000000.0, Pharmaceutical segment: 41289000000.0
FY2012Other Miscellaneous: 254000000.0, Other Segments: 6412000000.0, Pharmaceutical segment: 40601000000.0
FY2013Other Segments: 6596000000.0, Pharmaceutical segment: 37437000000.0
FY2014Other Segments: 6195000000.0, Pharmaceutical segment: 36042000000.0
FY2015Other Segments: 4716000000.0, Pharmaceutical segment: 34782000000.0
FY2016Other Segments: 4656000000.0, Pharmaceutical segment: 35151000000.0
FY2017Other Segments: 4732000000.0, Pharmaceutical segment: 35390000000.0
FY2018Animal Health segment: 4212000000.0, Other Segments: 393000000.0, Pharmaceutical segment: 37689000000.0
FY2019Animal Health segment: 4393000000.0, Other Segments: 696000000.0, Pharmaceutical segment: 41751000000.0
FY2020Animal Health segment: 4703000000.0, Other Segments: 23000000.0, Pharmaceutical segment: 43021000000.0
FY2021Animal Health segment: 5568000000.0, Other Segments: 382000000.0, Pharmaceutical segment: 42754000000.0
FY2022Animal Health segment: 5550000000.0, Other Segments: 1728000000.0, Pharmaceutical segment: 52005000000.0
FY2023Animal Health segment: 5625000000.0, Other Segments: 907000000.0, Pharmaceutical segment: 53583000000.0
FY2024Animal Health segment: 5877000000.0, Other Segments: 891000000.0, Pharmaceutical segment: 57400000000.0
FY2025Animal Health segment: 6354000000.0, Other Segments: 515000000.0, Pharmaceutical segment: 58142000000.0
Revenue by region
PeriodValue
FY2010EMEA: 13497000000.0, International: 8496000000.0, JAPAN: 3768000000.0, UNITED STATES: 20226000000.0
FY2011JAPAN: 4835000000.0, Segment, Geographical, Groups of Countries, Group One: 13782000000.0, Segment, Geographical, Groups of Countries, Group Two: 8935000000.0, UNITED STATES: 20495000000.0
FY2012EMEA: 12990000000.0, International: 8783000000.0, JAPAN: 5102000000.0, UNITED STATES: 20392000000.0
FY2013Asia Pacific: 3845000000.0, EMEA: 13140000000.0, International: 1555000000.0, JAPAN: 4044000000.0, Latin America: 3203000000.0, UNITED STATES: 18246000000.0
FY2014Asia Pacific: 3951000000.0, EMEA: 13174000000.0, International: 1419000000.0, JAPAN: 3471000000.0, Latin America: 3151000000.0, UNITED STATES: 17071000000.0
FY2015Asia Pacific: 3820000000.0, EMEA: 10677000000.0, International: 1986000000.0, JAPAN: 2673000000.0, Latin America: 2823000000.0, UNITED STATES: 17519000000.0
FY2016Asia Pacific: 3918000000.0, EMEA: 10953000000.0, International: 1457000000.0, JAPAN: 2846000000.0, Latin America: 2155000000.0, UNITED STATES: 18478000000.0
FY2017Asia Pacific: 4337000000.0, EMEA: 11478000000.0, International: 1422000000.0, JAPAN: 3122000000.0, Latin America: 2339000000.0, UNITED STATES: 17424000000.0
FY2018Asia Pacific: 2909000000.0, CHINA: 2184000000.0, EMEA: 12213000000.0, International: 1149000000.0, JAPAN: 3212000000.0, Latin America: 2415000000.0, UNITED STATES: 18212000000.0
FY2019Asia Pacific: 2943000000.0, CHINA: 3207000000.0, EMEA: 12707000000.0, International: 1606000000.0, JAPAN: 3583000000.0, Latin America: 2469000000.0, UNITED STATES: 20325000000.0
FY2020Asia Pacific: 2864000000.0, CHINA: 3624000000.0, EMEA: 13600000000.0, International: 1229000000.0, JAPAN: 3376000000.0, Latin America: 2274000000.0, UNITED STATES: 21027000000.0
FY2021Asia Pacific: 2407000000.0, CHINA: 4378000000.0, EMEA: 13341000000.0, International: 1221000000.0, JAPAN: 2726000000.0, Latin America: 2206000000.0, UNITED STATES: 22425000000.0
FY2022Asia Pacific: 3614000000.0, CHINA: 5191000000.0, EMEA: 14493000000.0, International: 2568000000.0, JAPAN: 3629000000.0, Latin America: 2582000000.0, UNITED STATES: 27206000000.0
FY2023Animal Health segment: 5625000000.0, Other Segments: 907000000.0, Pharmaceutical segment: 53583000000.0
FY2024Asia Pacific: 3058000000.0, CHINA: 5494000000.0, EMEA: 14041000000.0, International: 2559000000.0, JAPAN: 3280000000.0, Latin America: 3459000000.0, UNITED STATES: 32277000000.0
FY2025Asia Pacific: 2983000000.0, CHINA: 1939000000.0, EMEA: 14580000000.0, International: 2878000000.0, JAPAN: 2711000000.0, Latin America: 3410000000.0, UNITED STATES: 36510000000.0

Merck & Co (MRK) Stock Insights

MRK price $133.72 +0.91 +0.69%

Ticker
MRK
Price
$133.72
Change
+0.91 +0.69%
Market cap
$329.65B
P/E
133.40
Forward P/E
15.79
Dividend yield
2.26%
Beta
0.22
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
43
Value
38
Quality
61
Growth
30

Stocklytics score rationale: value 38, quality 61, growth 30.

AI Score 55. Merck & Co., Inc. has a high price-to-earnings ratio of approximately 153.4, indicating overvaluation relative to earnings

Summary

Merck & Co., Inc. operates in the Healthcare sector and Drug Manufacturers - General industry. The shares offer a dividend yield of 2.3%.

Valuation

The stock trades at a P/E ratio of 151.4 and a price-to-book ratio of 8.8. These multiples indicate a demanding valuation based on the provided measures.

Quality

Net margin is 3.6%, indicating profitability, though the provided information does not include balance-sheet, cash-flow, or return metrics.

Growth

No revenue, earnings-growth, estimate-revision, or price-trend data are provided, so growth cannot be assessed from the available facts.

Risks

The elevated P/E ratio of 151.4 creates valuation risk if earnings do not support the multiple. The net margin of 3.6% also provides limited evidence of profitability strength without additional operating context.

Insights

Revenue by product
PeriodValue
FY2011Other Segments: 53943000000.0, Pharmaceutical segment: 41289000000.0
FY2012Other Miscellaneous: 254000000.0, Other Segments: 6412000000.0, Pharmaceutical segment: 40601000000.0
FY2013Other Segments: 6596000000.0, Pharmaceutical segment: 37437000000.0
FY2014Other Segments: 6195000000.0, Pharmaceutical segment: 36042000000.0
FY2015Other Segments: 4716000000.0, Pharmaceutical segment: 34782000000.0
FY2016Other Segments: 4656000000.0, Pharmaceutical segment: 35151000000.0
FY2017Other Segments: 4732000000.0, Pharmaceutical segment: 35390000000.0
FY2018Animal Health segment: 4212000000.0, Other Segments: 393000000.0, Pharmaceutical segment: 37689000000.0
FY2019Animal Health segment: 4393000000.0, Other Segments: 696000000.0, Pharmaceutical segment: 41751000000.0
FY2020Animal Health segment: 4703000000.0, Other Segments: 23000000.0, Pharmaceutical segment: 43021000000.0
FY2021Animal Health segment: 5568000000.0, Other Segments: 382000000.0, Pharmaceutical segment: 42754000000.0
FY2022Animal Health segment: 5550000000.0, Other Segments: 1728000000.0, Pharmaceutical segment: 52005000000.0
FY2023Animal Health segment: 5625000000.0, Other Segments: 907000000.0, Pharmaceutical segment: 53583000000.0
FY2024Animal Health segment: 5877000000.0, Other Segments: 891000000.0, Pharmaceutical segment: 57400000000.0
FY2025Animal Health segment: 6354000000.0, Other Segments: 515000000.0, Pharmaceutical segment: 58142000000.0
Revenue by region
PeriodValue
FY2010EMEA: 13497000000.0, International: 8496000000.0, JAPAN: 3768000000.0, UNITED STATES: 20226000000.0
FY2011JAPAN: 4835000000.0, Segment, Geographical, Groups of Countries, Group One: 13782000000.0, Segment, Geographical, Groups of Countries, Group Two: 8935000000.0, UNITED STATES: 20495000000.0
FY2012EMEA: 12990000000.0, International: 8783000000.0, JAPAN: 5102000000.0, UNITED STATES: 20392000000.0
FY2013Asia Pacific: 3845000000.0, EMEA: 13140000000.0, International: 1555000000.0, JAPAN: 4044000000.0, Latin America: 3203000000.0, UNITED STATES: 18246000000.0
FY2014Asia Pacific: 3951000000.0, EMEA: 13174000000.0, International: 1419000000.0, JAPAN: 3471000000.0, Latin America: 3151000000.0, UNITED STATES: 17071000000.0
FY2015Asia Pacific: 3820000000.0, EMEA: 10677000000.0, International: 1986000000.0, JAPAN: 2673000000.0, Latin America: 2823000000.0, UNITED STATES: 17519000000.0
FY2016Asia Pacific: 3918000000.0, EMEA: 10953000000.0, International: 1457000000.0, JAPAN: 2846000000.0, Latin America: 2155000000.0, UNITED STATES: 18478000000.0
FY2017Asia Pacific: 4337000000.0, EMEA: 11478000000.0, International: 1422000000.0, JAPAN: 3122000000.0, Latin America: 2339000000.0, UNITED STATES: 17424000000.0
FY2018Asia Pacific: 2909000000.0, CHINA: 2184000000.0, EMEA: 12213000000.0, International: 1149000000.0, JAPAN: 3212000000.0, Latin America: 2415000000.0, UNITED STATES: 18212000000.0
FY2019Asia Pacific: 2943000000.0, CHINA: 3207000000.0, EMEA: 12707000000.0, International: 1606000000.0, JAPAN: 3583000000.0, Latin America: 2469000000.0, UNITED STATES: 20325000000.0
FY2020Asia Pacific: 2864000000.0, CHINA: 3624000000.0, EMEA: 13600000000.0, International: 1229000000.0, JAPAN: 3376000000.0, Latin America: 2274000000.0, UNITED STATES: 21027000000.0
FY2021Asia Pacific: 2407000000.0, CHINA: 4378000000.0, EMEA: 13341000000.0, International: 1221000000.0, JAPAN: 2726000000.0, Latin America: 2206000000.0, UNITED STATES: 22425000000.0
FY2022Asia Pacific: 3614000000.0, CHINA: 5191000000.0, EMEA: 14493000000.0, International: 2568000000.0, JAPAN: 3629000000.0, Latin America: 2582000000.0, UNITED STATES: 27206000000.0
FY2023Animal Health segment: 5625000000.0, Other Segments: 907000000.0, Pharmaceutical segment: 53583000000.0
FY2024Asia Pacific: 3058000000.0, CHINA: 5494000000.0, EMEA: 14041000000.0, International: 2559000000.0, JAPAN: 3280000000.0, Latin America: 3459000000.0, UNITED STATES: 32277000000.0
FY2025Asia Pacific: 2983000000.0, CHINA: 1939000000.0, EMEA: 14580000000.0, International: 2878000000.0, JAPAN: 2711000000.0, Latin America: 3410000000.0, UNITED STATES: 36510000000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener